Centro Hospitalar Universitário de São João

Porto 4200-319

1 studies enrolling now · 7 studies all time

What they study most

Heart Failure, Metastatic Non Small Cell Lung Cancer, Parkinson´s Disease, SARS-CoV2 Infection, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Studies at this site

• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) — Enrolling by invitation
• Rostock International Parkinson's Disease Study (ROPAD) — Completed
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
• CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING